Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by enriquesuave


V.TLT

Animal Covid-19 studies to begin in May or June as per MD&A

Q2 was stated for commencement of animal studies.  They showed a COVID...

May 3, 2022

V.TLT

RE:RE:RE:RE:RE:Finally! Easy to parse data!

enriquesuave wrote: You posted the chart of All treated patients which...

May 3, 2022

V.TLT

RE:RE:RE:RE:Finally! Easy to parse data!

You posted the chart of All treated patients which includes 1st set of 12 who...

May 3, 2022

V.TLT

RE:Finally! Easy to parse data!

The Best part is that in the Optimized group, they went from April 5th...

May 3, 2022

V.TLT

RE:Positive MD&A Tidbits

Nice find Eoganacht.  I rechecked data charts   Looks like a few...

May 2, 2022

V.TLT

RE:RE:RE:RE:RE:AUA Meeting 2022 - 13-16 May 2022

I agree there, but eventually it would be nice to partner with Big Pharma...

May 2, 2022

V.TLT

Other Indications Impressive Preclinical Data

Colorectal preclinical subcutaneous mouse model Rutherin + X-Rays  Vs X...

May 1, 2022

V.TLT

RE:RE:RE:RE:The Good News

I think a lot of short term traders sold the news.  For sure a lot of...

May 1, 2022

V.TLT

RE:Observation/Question

It costs money to submit a BTD application, so they want to get it right the...

May 1, 2022

V.TLT

RE:The Good News

Just to combine today's post with my earlier post this past week.  I...

April 30, 2022

V.TLT

RE:The Good News

"For evaluable patients, who completed Study II, who achieved a CR at 90...

April 30, 2022

V.TLT

The Good News

"For evaluable patients, who completed Study II, who achieved a CR at 90...

April 30, 2022

V.TLT

Conference

Sherri will be busy this month.    https://www.fusion-conferences...

April 29, 2022

V.TLT

RE:The Key to Theralase ACT

This is correct, the 2 factors that contribute to Tumor cell kill for PDT are...

April 29, 2022

V.TLT

RE:RE:quarterly -financials ??

Also Q1 results by May31 and who knows news along the way? enriquesuave...

April 29, 2022

V.TLT

RE:quarterly -financials ??

Most probably Monday or today after market closes? Legit62 wrote: Does...

April 29, 2022

V.TLT

RE:RE:RE:One more look at the new 90 day optimized data

In the Keytruda trial, 5 patients were droppe from the 101 who got treated as...

April 28, 2022

V.TLT

RE:One more look at the new 90 day optimized data

An analysis of NR patients in overall data on all 38 patients, we have 3...

April 28, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:Half Of Breakthrough Designations Have Resulted In Approval

Waiting on patient updates.  PR patients final status. Perhaps more...

April 27, 2022

V.TLT

RE:RE:The Theralase Project

Yes definitely thought provoking.  I still see TLD-1433 shaping up to be...

April 26, 2022